0.3557
Schlusskurs vom Vortag:
$0.3563
Offen:
$0.3545
24-Stunden-Volumen:
89,683
Relative Volume:
0.25
Marktkapitalisierung:
$8.23M
Einnahmen:
$81.89M
Nettoeinkommen (Verlust:
$-55.20M
KGV:
-0.1319
EPS:
-2.6959
Netto-Cashflow:
$-67.40M
1W Leistung:
-0.86%
1M Leistung:
-5.07%
6M Leistung:
-17.28%
1J Leistung:
-85.48%
Turnstone Biologics Corp Stock (TSBX) Company Profile
Firmenname
Turnstone Biologics Corp
Sektor
Branche
Telefon
347-897-5988
Adresse
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Vergleichen Sie TSBX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TSBX
Turnstone Biologics Corp
|
0.3557 | 8.30M | 81.89M | -55.20M | -67.40M | -2.6959 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-11-15 | Herabstufung | BofA Securities | Neutral → Underperform |
2024-10-14 | Herabstufung | BofA Securities | Buy → Neutral |
2023-08-16 | Eingeleitet | SVB Securities | Market Perform |
2023-08-15 | Eingeleitet | BofA Securities | Buy |
2023-08-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Turnstone Biologics Corp Aktie (TSBX) Neueste Nachrichten
What analysts say about Turnstone Biologics Corp. stockConsistently high yield - jammulinksnews.com
Is Turnstone Biologics Corp. a good long term investmentFree Stock Chart Pattern Guide - jammulinksnews.com
Turnstone Biologics Corp. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
What drives Turnstone Biologics Corp. stock priceUnmatched profit growth - Autocar Professional
Why Turnstone Biologics Corp. stock attracts strong analyst attentionOptimized Return Investment Picks - Newser
What makes Turnstone Biologics Corp. stock price move sharplyVerified Chart Patterns - Newser
How Turnstone Biologics Corp. stock performs during market volatilityLow Risk Trade Timing Signals - Newser
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve
How did TSBX's revenue and expenses trend in Q4 2024? - AInvest
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX) - TradingView
Turnstone Biologics To Merge With Biotech Royalty Aggregator XOMA, But Retail Sentiment Slumps - MSN
TSBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Turnstone Biologics Corp. Is Fair to Shareholders - Bluefield Daily Telegraph
Millennium Management LLC Cuts Position in Turnstone Biologics Corp. (NASDAQ:TSBX) - Defense World
Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World
Check out Turnstone Biologics Corp's stock price (TSBX) in real time - CNBC
Turnstone Biologics Reports Q1 Loss Amid Strategic Shift - TipRanks
Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025 - MarketScreener
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights - The Manila Times
Turnstone Biologics Reports Q1 2025 Financial Results and Updates on Strategic Alternatives - Nasdaq
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent - Bluefield Daily Telegraph
Turnstone Biologics (NASDAQ:TSBX) Shares Up 0.8% – Still a Buy? - Defense World
Turnstone Biologics stock plunges to 52-week low of $0.29 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.29 - Investing.com Australia
Turnstone Biologics stock plunges to 52-week low of $0.33 By Investing.com - Investing.com South Africa
Finanzdaten der Turnstone Biologics Corp-Aktie (TSBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):